Outcomes of concomitant myectomy and left ventricular apical aneurysm repair in patients with hypertrophic cardiomyopathy

Objectives: Hypertrophic cardiomyopathy with left ventricular apical aneurysm is a phenotype associated with a 4-fold increase in the risk for sudden cardiac death. In this study, we describe the surgical outcome of concomitant apical aneurysm repair in patients undergoing transapical myectomy for hypertrophic cardiomyopathy. Methods: We identi fi ed 67 patients with left ventricular apical aneurysms who underwent transapical myectomy and apical aneurysm repair between July 2000 and August 2020. Long -term survival was compared with that of 2746 consecutive patients undergoing transaortic septal myectomy for obstructive hypertrophic cardiomyopathy with subaortic obstruction. Results: Transapical myectomy was indicated for midventricular obstruction (n = 44) or left ventricular remodeling for diastolic heart failure (n = 29). Preoperatively, 74.6 % (n = 50) of patients were in New York Heart Association class III/IV heart failure, and 34.3 % (n = 23) of patients had experienced syncope or presyncope. Atrial fi brillation was documented in 22 patients (32.8 % ), and episodes of ventricular arrhythmias were recorded in 30 patients (44.8 % ). Thrombus was present in the apical aneurysm in 6 patients. During a median (interquartile range) follow-up of 4.9 (1.8-7.6) years, the estimated 1- and 5-year survivals were 98.5 % and 94.5 % , respectively, which were not signi fi cantly different from that of patients undergoing transaortic septal myectomy for obstructive hypertrophic cardiomyopathy ( P = .52) or an age- and sex-matched US general population ( P = .40). Conclusions: Apical aneurysm repair in conjunction with septal myectomy is a safe procedure, and the good long-term survival of patients suggests that the procedure may reduce cardiac-related death in this high-risk hypertrophic cardiomyopathy population. (J Thorac Cardiovasc Surg 2024;168:96-103)